|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00000473 |
Purpose
To determine whether a dietary supplement of n-3 polyunsaturated fatty acids (PUFAs) derived from fish oil would decrease the restenosis rate in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
| Condition | Intervention | Phase |
|
Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia |
Behavioral: dietary supplements Drug: fatty acids, omega-3 Behavioral: diet, fat-restricted |
Phase III |
| MedlinePlus related topics: | Angioplasty Dietary Supplements Heart Diseases |
| Drug Information available for: | Fish oil |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Double-Blind |
Eligibility
| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Men and women with coronary heart disease in the native coronary arteries. Patients were symptomatic or had 50 percent or greater stenosis as defined by coronary angiography.
Patients had not undergone prior angioplasty.
Contacts and Locations
More Information
| Study ID Numbers: | 62 |
| First Received: | October 27, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000473 |
| Health Authority: | United States: Federal Government |
|
|